Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)

SHA:600664 Revenue

Harbin Pharmaceutical Group had revenue of 4.18B CNY in the quarter ending March 31, 2026, with 0.02% growth. This brings the company's revenue in the last twelve months to 15.96B, down -1.50% year-over-year. In the year 2025, Harbin Pharmaceutical Group had annual revenue of 15.96B, down -1.31%.

• Revenue (ttm): 15.96B
• Revenue Growth: -1.50%
• P/S Ratio: 0.91
• Revenue / Employee: 1.59M
• Employees: 10,039
• Market Cap: 14.46B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	15.96B	-211.79M	-1.31%
Dec 31, 2024	16.18B	719.28M	4.65%
Dec 31, 2023	15.46B	1.65B	11.93%
Dec 31, 2022	13.81B	1.01B	7.86%
Dec 31, 2021	12.80B	2.01B	18.66%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 25, 2026

Data Sources Report a data error